These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 8697616

  • 41. Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis.
    Dolman KM, Stegeman CA, van de Wiel BA, Hack CE, von dem Borne AE, Kallenberg CG, Goldschmeding R.
    Clin Exp Immunol; 1993 Sep; 93(3):405-10. PubMed ID: 8370167
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitides.
    Csernok E, Schmitt WH, Ernst M, Bainton DF, Gross WL.
    Adv Exp Med Biol; 1993 Sep; 336():45-50. PubMed ID: 8296655
    [Abstract] [Full Text] [Related]

  • 44. [ANCA-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). 1. Systemic aspects, pathogenesis and clinical aspects].
    Gross WL, Reinhold-Keller E.
    Z Rheumatol; 1995 Sep; 54(5):279-90. PubMed ID: 8578884
    [Abstract] [Full Text] [Related]

  • 45. Neutrophil activation in vitro and in vivo in Wegener's granulomatosis.
    Brouwer E, Huitema MG, Mulder AH, Heeringa P, van Goor H, Tervaert JW, Weening JJ, Kallenberg CG.
    Kidney Int; 1994 Apr; 45(4):1120-31. PubMed ID: 8007582
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
    Russell KA, Fass DN, Specks U.
    Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
    [Abstract] [Full Text] [Related]

  • 48. Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies.
    Reumaux D, Vossebeld PJ, Roos D, Verhoeven AJ.
    Blood; 1995 Oct 15; 86(8):3189-95. PubMed ID: 7579414
    [Abstract] [Full Text] [Related]

  • 49. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.
    van der Geld YM, Tool AT, Videler J, de Haas M, Tervaert JW, Stegeman CA, Limburg PC, Kallenberg CG, Roos D.
    Clin Exp Immunol; 2002 Sep 15; 129(3):562-70. PubMed ID: 12197900
    [Abstract] [Full Text] [Related]

  • 50. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.
    Van Der Geld YM, Simpelaar A, Van Der Zee R, Tervaert JW, Stegeman CA, Limburg PC, Kallenberg CG.
    Kidney Int; 2001 Jan 15; 59(1):147-59. PubMed ID: 11135067
    [Abstract] [Full Text] [Related]

  • 51. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
    Savige JA, Paspaliaris B, Silvestrini R, Davies D, Nikoloutsopoulos T, Sturgess A, Neil J, Pollock W, Dunster K, Hendle M.
    J Clin Pathol; 1998 Aug 15; 51(8):568-75. PubMed ID: 9828813
    [Abstract] [Full Text] [Related]

  • 52. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
    Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, Lesavre P, Lüdemann J, Rasmussen N, Sinico RA, Wiik A, van der Woude FJ.
    Kidney Int; 1998 Mar 15; 53(3):743-53. PubMed ID: 9507222
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for anti-neutrophil cytoplasmic antibodies (ANCA).
    Specks U, Wiegert EM, Homburger HA.
    Clin Exp Immunol; 1997 Aug 15; 109(2):286-95. PubMed ID: 9276524
    [Abstract] [Full Text] [Related]

  • 55. Proteinase 3 gene polymorphisms and Wegener's granulomatosis.
    Gencik M, Meller S, Borgmann S, Fricke H.
    Kidney Int; 2000 Dec 15; 58(6):2473-7. PubMed ID: 11115080
    [Abstract] [Full Text] [Related]

  • 56. No association between neutrophil FcgammaRIIa allelic polymorphism and anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis.
    Tse WY, Abadeh S, McTiernan A, Jefferis R, Savage CO, Adu D.
    Clin Exp Immunol; 1999 Jul 15; 117(1):198-205. PubMed ID: 10403936
    [Abstract] [Full Text] [Related]

  • 57. Wegener's granulomatosis: anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response.
    Sibelius U, Hattar K, Schenkel A, Noll T, Csernok E, Gross WL, Mayet WJ, Piper HM, Seeger W, Grimminger F.
    J Exp Med; 1998 Feb 16; 187(4):497-503. PubMed ID: 9463400
    [Abstract] [Full Text] [Related]

  • 58. Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis?
    Kallenberg CG, Tervaert JW, van der Woude FJ, Goldschmeding R, von dem Borne AE, Weening JJ.
    Immunol Today; 1991 Feb 16; 12(2):61-4. PubMed ID: 1647776
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Genetic impact of pathogenesis and prognosis of ANCA-associated vasculitides.
    Borgmann S, Haubitz M.
    Clin Exp Rheumatol; 2004 Feb 16; 22(6 Suppl 36):S79-86. PubMed ID: 15675141
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.